Overwhelming demand for transformative GLP-1 agonists like Ozempic and Mounjaro has led to widespread compounding and a boom in counterfeiting.

Several states are trying to reduce healthcare costs by importing medicine from countries where it costs less, but this is a deeply flawed policy proposal.

Pharmacy Benefit Managers' under-reimbursements make pharmacies perfect targets for counterfeiters—and make the U.S. drug supply less safe as a result.

State Prescription Drug Affordability Boards intend to control medicine costs — but some of their strategies will have unintended consequences.

After two decades of tracking counterfeit drugs, PSM is an expert on medicine safety issues and we often offer journalists our insight and perspective. 

Colorado Department of Regulatory Agencies updates Joint Budget Committee on litigation costs

April 1, 2025

Colorado Department of Regulatory Agencies updates Joint Budget Committee on litigation costs According to a March 12, 2025 memo from Colorado’s Department of Regulatory Agencies to its Joint Budget Committee said the state had paid more than $150,000 defending itself in a lawsuit Amgen had filed over plans to set an upper payment limit on…

March 31, 2025: Senator asks how FDA will be accountable for unregulated active pharmaceutical ingredient (API) imports

March 31, 2025

Senator Jim Banks asked pointed questions about how FDA will stem the tide of semaglutide and tirzepatide coming from unknown facilities.

March 24, 2025: Cost-saving AFPs are exposing Americans to risky, unregulated medicine

March 24, 2025

“Alternative funding programs” are shifting expensive prescription coverage to illegal drug importation schemes.

PSM submits comment on CBP’s proposed rules to improve screening of low-value shipments

March 19, 2025

On March 14, the Partnership for Safe Medicines submitted comment on Customs and Border Protection’s proposed update to regulations around low-value, “de minimus” shipments.

March 17, 2025: A Texas Pharmacist gets 17 years for $145m skin cream billing fraud

March 18, 2025
a brown pharmacy building on a concrete lot on an overcast day

A Texas man billed government programs millions for creams compounded by untrained teenagers. News about counterfeit medicine in six U.S. states.

March 10, 2025: Patients transitioning from compounded diabetes / weight loss injections: Stick to licensed sources

March 10, 2025
Vials of black market weight loss drugs

FDA’s shutdown of GLP-1 compounding could lead to a new era of risk for U.S. patients.

Like your information on video? Subscribe to our YouTube playlist!

youtube-video-thumbnail

How is unapproved semaglutide and tirzapetide getting into the US?

youtube-video-thumbnail

Why should fake drugs overseas matter to me? Watch.

Watch to learn who HSI arrested and why and keep track here. 

Click the images below to see more recent videos.